A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy

NCT01087203 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

73

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetic Peripheral Neuropathy

Interventions

BIOLOGICAL: Tanezumab
BIOLOGICAL: placebo

Sponsor

Pfizer